Shannon Blalock

Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.

Keefe, Bruyette & Woods, Inc. (KBW) is a full-service investment bank and broker/dealer headquartered in New York City. The firm was founded in 1962 and is a subsidiary of Stifel Financial Corp. (NYSE: SF). KBW offers sales and trading in equities securities of financial services companies.

ClearSky Power & Technology Partners LLC (ClearSky) is a private equity/venture capital firm co-founded in 2012 by James Huff and Jay Leek. The firm is headquartered in Juno Beach, Florida with offices in New York and San Francisco.

Inky Technology Corp. operates as cyber security expert against email phishing and other email-based attacks. The firm offers content based checks, cryptographic checks and known threat database checks. The company was founded by Dave Baggett, Simionato Nicola and Simon Smith and is headquartered in College Park, MD.

J.F. Lehman & Co. (JF Lehman) is a private equity firm founded by John Francis Lehman, Donald Glickman and Keith E. Oster in 1992. The firm is headquartered in New York with an additional office in Arlington, Virginia.

In-Q-Tel is a Venture Capital firm is founded in 1999 by Gilman Louie. The firm is headquartered in Arlington with additional office in London, United Kingdom.

Actus Digital provides web-based media monitoring, content repurposing and verification for broadcasters, cable and satellite providers, IPTV, media and monitoring agencies, governments and content producers. Its products include Actus View, Actus Clip Factory, Actus rating analyzer, Actus Adwatch and Actus Mosaic. The company is headquartered in Uccle, Belgium.

Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation.